A Phase 1 Clinical Study of AZD4635 in Patients With Advanced Solid Malignancies

Clinical trial NCT02740985 · COMPLETED

Trial details

NCT number: NCT02740985
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Malignancies Non-Small Cell Lung Cancer (NSCLC)Metastatic Castrate-Resistant Prostate Carcinoma (mCRPC)Colorectal Carcinoma (CRC)

Start date: 2016-06-17
Primary completion: 2020-12-31
Enrollment: 313

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.